Nevro Corp. (NVRO)
NYSE: NVRO · Real-Time Price · USD
4.520
+0.160 (3.67%)
At close: Nov 22, 2024, 4:00 PM
4.300
-0.220 (-4.87%)
After-hours: Nov 22, 2024, 7:30 PM EST
Nevro Market Cap
Nevro has a market cap or net worth of $169.37 million as of November 22, 2024. Its market cap has decreased by -71.34% in one year.
Market Cap
169.37M
Enterprise Value
139.27M
1-Year Change
-71.34%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since November 6, 2014, Nevro's market cap has decreased from $574.20M to $169.37M, a decrease of -70.50%. That is a compound annual growth rate of -11.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 158.90M | -79.60% |
| Dec 29, 2023 | 779.10M | -44.47% |
| Dec 30, 2022 | 1.40B | -50.42% |
| Dec 31, 2021 | 2.83B | -52.52% |
| Dec 31, 2020 | 5.96B | 63.52% |
| Dec 31, 2019 | 3.64B | 210.75% |
| Dec 31, 2018 | 1.17B | -42.66% |
| Dec 29, 2017 | 2.05B | -2.13% |
| Dec 30, 2016 | 2.09B | 10.82% |
| Dec 31, 2015 | 1.89B | 96.32% |
| Dec 31, 2014 | 960.70M | 67.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| scPharmaceuticals | 173.14M |
| Actuate Therapeutics | 172.85M |
| Stereotaxis | 172.42M |
| Nkarta | 172.19M |
| Instil Bio | 171.37M |
| KORU Medical Systems | 165.08M |
| Candel Therapeutics | 164.39M |
| Heron Therapeutics | 164.26M |